Your browser doesn't support javascript.
loading
In vivo activation of Treg cells with a CD28 superagonist prevents and ameliorates chronic destructive arthritis in mice.
Win, Stephanie J; Kühl, Anja A; Sparwasser, Tim; Hünig, Thomas; Kamradt, Thomas.
Affiliation
  • Win SJ; Institute of Immunology, Universitätsklinikum Jena, Jena, Germany.
  • Kühl AA; Department of Medicine 1-Gastroenterology, Infectious Diseases and Rheumatology and Research Centre ImmunoSciences, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Sparwasser T; Institute for Infection Immunology, Centre for Experimental and Clinical Infection Research, TWINCORE, Hannover, Germany.
  • Hünig T; Institute of Virology and Immunobiology, University of Würzburg, Würzburg, Germany.
  • Kamradt T; Institute of Immunology, Universitätsklinikum Jena, Jena, Germany.
Eur J Immunol ; 46(5): 1193-202, 2016 05.
Article de En | MEDLINE | ID: mdl-26711629

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Arthrite expérimentale / Maladies auto-immunes / Lymphocytes T régulateurs / Antigène CD28 / Anticorps monoclonaux Type d'étude: Prognostic_studies Limites: Animals Langue: En Journal: Eur J Immunol Année: 2016 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Allemagne

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Arthrite expérimentale / Maladies auto-immunes / Lymphocytes T régulateurs / Antigène CD28 / Anticorps monoclonaux Type d'étude: Prognostic_studies Limites: Animals Langue: En Journal: Eur J Immunol Année: 2016 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Allemagne